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Abstract
Background: Volume overload in hemodialysis patients is an independent risk factor for cardiovascular event-
related mortality. The number of B-lines observed using lung ultrasound is correlated with the severity of
pulmonary congestion. The aim of this study was to evaluate the association between the number of B-lines and
mortality among hemodialysis patients.
Methods: A total of 61 patients receiving maintenance hemodialysis were enrolled in this study. Clinical data
including age, sex, duration of hemodialysis therapy, presence of diabetes mellitus and/or hypertension and/or
dyslipidemia complications, the results of biological examinations, and outcome were collected from the patients’
clinical records. We performed echographic examinations at three time points (just after the start, during the
middle, and just before the end of hemodialysis therapy). A univariate Cox proportional hazard model was used to
identify predictors of the overall outcomes. Furthermore, we divided patients into two groups according to the
median number of the B-lines at the end of dialysis and compared the mortality between the two groups.
Results: The mean follow-up period was 507 ± 385 days. During the follow-up period, 24 deaths were recorded.
Predictive variables for mortality included age; serum level of albumin, creatinine, and N-terminal pro-brain
natriuretic peptide; and body weight (P < 0.001, P < 0.0001, P < 0.001, P = 0.014, and P = 0.019, respectively). The
number of B-lines at the start, middle, and end of dialysis therapy was correlated with mortality (hazard ratio (95%
confidence interval) 1.20 (1.09–1.32), P = 0.0002; 1.17 (1.07–1.28), P = 0.0008; and 1.23 (1.12–1.37), P = 0.0001;
respectively). The mortality was statistically higher in the group with 5 or more B-lines than in the group with less
than 5 B-lines (P = 0.013).
Conclusions: The number of B-lines at the start, middle, and end of hemodialysis therapy may be correlated with
mortality among hemodialysis patients.
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Background
Volume overload in hemodialysis patients is an independ-
ent risk factor for death from cardiovascular events [1].
Proper evaluation of the intracellular and extracorporeal
volumes to set the proper correct dry weight is important
for hemodialysis patients. Many methods have been utilized
to assess the volume statuses of hemodialysis patients.
Lung ultrasound has recently been shown to be a useful,
noninvasive technique for the assessment of extravascular
lung water [2]. The most commonly observed finding is a
comet tail artifact fanning out from the lung-wall interface
and spreading upwards to the edge of the screen, previ-
ously named a “B-line” [3]. In patients with heart failure,
the number of B-lines is correlated with the degree of
extravascular lung water [4, 5]. The pre-dialysis number of
B-lines significantly correlated with whole-body bioimpe-
dance spectroscopy device-derived extracellular water in
hemodialysis patients [6]. Vitturi et al. investigated lung
and bioimpedance spectroscopy results immediately before
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
* Correspondence: sotsubo@hb.tp1.jp
1Department of Medicine, Kidney Center, Tokyo Women’s Medical University,
Tokyo, Japan
4Department of Blood Purification, Tohto Sangenjaya Clinic, 2-13-2 Taishido,
Setagaya-ku, Tokyo 154-0004, Japan
Full list of author information is available at the end of the article
Kawachi et al. Renal Replacement Therapy            (2019) 5:27 
https://doi.org/10.1186/s41100-019-0223-x
and after dialysis and reported that a reduction in the num-
ber of B-lines was correlated with fluid loss as a result of
hemodialysis, conforming that lung ultrasound can identify
extravascular lung water. The number of post-dialysis B-
lines is correlated with the residual weight assessed using
bioimpedance, suggesting a role for ultrasound in the man-
agement of hemodialysis patients [7]. Lung ultrasound is
also reportedly useful for the accurate evaluation of dry
weight and fluid status in hemodialysis patients [2, 8, 9].
The number of B-lines observed using lung ultrasound
represents the severity of pulmonary congestion [10].
The relationship between pre-hemodialysis number of
B-lines and mortality was already reported [6]. Another
investigator reported that the number of B-lines at the
end of hemodialysis therapy was related to mortality
[11]. There was no report which investigates the rela-
tionship between the number of B-lines at the middle of
hemodialysis therapy and mortality.
The aim of this study was to evaluate the association
between the number of B-lines at three points (at the
start, the middle, and the end) and mortality among
hemodialysis patients.
Methods
A total of 61 patients receiving maintenance hemodialysis
at Sekikawa Hospital were enrolled in this study. Clinical
data including age, sex, duration of hemodialysis therapy,
presence of diabetes mellitus and/or hypertension and/or
dyslipidemia complications, the results of biological exam-
inations, and outcome were collected from the patients’
clinical records. Hypertension was defined as a systolic
blood pressure of 140mmHg or higher, a diastolic blood
pressure of 90mmHg or higher, and/or the current use of
antihypertensive drugs. Diabetes mellitus was defined as a
fasting glucose level ≥ 126mg/dL, a nonfasting glucose
level ≥ 200mg/dL, or the use of medication. Dyslipidemia
was defined as a low-density lipoprotein-cholesterol level
≥ 140mg/dL, a high-density lipoprotein-cholesterol level
< 40mg/dL, a triglyceride level ≥ 150mg/dL, or the use of
medication. A peripheral blood sample was obtained be-
fore hemodialysis during the first session of the week. The
serum N-terminal pro-brain natriuretic peptide (NT-
proBNP) level in the pre-dialysis blood sample was mea-
sured using an electrochemiluminescence immunoassay
on an Elecsys platform (Roche, Basel, Switzerland).
A lung ultrasound examination was performed during
the first session of the week (at the same time as the
peripheral blood sample preparation) using Vscan® (GE
Healthcare, Japan), which is a hand-held ultrasound de-
vice with a wide-bandwidth phased-array probe (1.7–3.5
MHz) [12, 13]. Bilateral scanning of the anterior and lat-
eral chest walls was performed with the patient in a su-
pine position. An intercostal scan with a maximum
extension of the visual pleural line was performed. The
chest wall was divided into eight areas (two anterior and
two lateral areas per side), and one scan was obtained
for each area [14]. The anterior zone of the chest wall
was designated as the area from the sternum to the an-
terior axillary line and was then divided into upper and
lower halves (from the clavicle to the third intercostal
space and from the third space to the diaphragm). The
lateral zone was positioned from the anterior axillary
line to the posterior axillary line and was also divided
into the upper and lower halves. The investigator
attempted to detect comet tail artifacts fanning out from
the lung-wall interface and spreading to the edge of the
screen, which were previously named B-lines [5, 8]. The
total number of B-lines was estimated. Echocardio-
graphic measurements were obtained at the same time,
and the inferior vena cava (IVC) dimensions and the
peak early mitral inflow wave velocity (peak E-velocity)
were estimated using VividS60® (GE Healthcare, Japan).
One expert cardiologist, who is blind to the result of
blood peripheral blood sample, underwent both lung
and cardiac echo examinations. He performed echo-
graphic examinations three times (just after the start,
during the middle, and just before the end of the
hemodialysis therapy). Furthermore, we divided patients
into two groups according to the median number of the
B-lines at the end of dialysis and compared the mortality
between the two groups.
The data were expressed as the means ± S.D. or the me-
dian (interquartile range; IQR). To evaluate the associ-
ation between the number of B-lines and mortality,
univariate Cox proportional hazard model was used to
examine the predictors of the overall outcomes. The sur-
vival curves were estimated using the Kaplan–Meier
method. To evaluate the association between the number
of B-lines and mortality among hemodialysis patients, a
log-rank test was used to compare mortality between the
group with a high number of B-lines and the group with a
low number of B-lines. All the statistical calculations were
performed using JMP 5.1 software. P values less than 0.05
were considered statistically significant. This study was
conducted in accordance with the principles of the Declar-
ation of Helsinki and was permitted by the research ethics
committee of Sekikawa Hospital (Approved No. H2705).
Results
The patient background characteristics are shown in
Table 1. The mean age was 75.2 ± 10.7 years. Diabetic
nephropathy was the major cause of end-stage kidney
disease (45.9%). Hypertension, diabetes mellitus, and
dyslipidemia were present in 86.9%, 45.9%, and 18.0% of
the study participants, respectively. The serum albumin
level was relatively low (3.1 ± 0.6 g/dL), and the serum
NT-proBNP level was relatively high (13,851 [4764–34,
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279]) pg/mL) among the study participants. The mean
ejection fraction was 60.1 ± 13.4%.
The treatment time was 3.7 ± 0.4 h. All participants
did not have symptoms of dyspnea and did not undergo
oxygen therapy. There was no patient with proteinuria
at the nephrotic level. None underwent albumin or
blood transfusion during the hemodialysis therapy.
Table 2 shows the changes in the echocardiographic in-
dices. The number of B-lines decreased from 11.8 ± 5.5
at the start of the therapy to 9.3 ± 5.3 during the middle
and 5.2 ± 4.5 at the end of the therapy. The peak E-
velocity also decreased from 78.0 ± 25.8 cm/s at the start
of the therapy to 57.5 ± 20.8 cm/s during the middle and
51.4 ± 20.3 cm/s at the end of the therapy. The IVC-
exhalation dimensions also decreased from 15.3 ± 3.8
mm at the start of the therapy to 12.0 ± 3.5 mm during
the middle and 10.6 ± 3.4 mm at the end of the therapy.
The mean follow-up period was 507 ± 385 days. Dur-
ing the follow-up period, 24 deaths (including 12 from
infection, 8 from heart failure, 2 from malignant tumors,
and 2 from other causes) were recorded.
Table 3 shows a Cox proportional hazards analysis of
the covariates for predicting mortality. In the univariate
regression analysis, predictive variables for mortality in-
cluded age; serum level of albumin, creatinine, and NT-
proBNP; and body weight (P < 0.001, P < 0.0001, P < 0.001,
P = 0.014, and P = 0.019, respectively). Ultrafiltration rate
(UFR), UFR/body weight, and ΔB-lines/B-lines at the start
also associated with mortality (P = 0.004, P = 0.042, and
P = 0.027, respectively). Elder, low serum level of albumin
and creatinine, high serum level of NT-proBNP, and low
level of UFR, UFR/body weight, and ΔB-lines/B-lines at
the start were risk factors for mortality.
Table 4 shows the results of the same Cox propor-
tional hazards analysis focusing on the echocardio-
graphic changes during hemodialysis therapy. Significant
factors related to mortality were the number of B-lines
at the start (hazard ratio (95% confidence interval); 1.20
(1.09–1.32), P = 0.0002), middle (1.17 (1.07–1.28), P =
0.0008), and end (1.23 (1.12–1.37), P = 0.0001) of dialysis
therapy. A large number of B-lines at any point resulted
in poor outcome. The number of B-lines at the end of
hemodialysis therapy was the most significant factor as-
sociated with mortality.
The medium number of B-lines at the end of
hemodialysis therapy was 4, so we divided patients
into two groups, the “5 or more” group (n = 30) and
the “less than 5” group (n = 31). Figure 1 shows the
comparison of survival curves between the 5 or
more group and less than 5 group. One-year survival
was 55.4% in the 5 or more group whereas it was
89.8% in less than 5 group. The mortality was statis-
tically higher in the 5 or more group than the less
than 5 group (P = 0.013).
Table 1 Background characteristics of the study participants
Characteristic Quantity
Gender (M/F) 29/32
Age (year) 75.2 ± 10.7
Duration of HD (year) 6.2 ± 8.4
Primary cause of ESKD, n (%)
Chronic glomerulonephritis 10 (16.4)
Diabetic nephropathy 28 (45.9)
Nephrosclerosis 13 (21.3)
Unknown and others 10 (16.4)
Hypertension, n (%) 53 (86.9)
Diabetes mellitus, n (%) 28 (45.9)
Dyslipidemia, n (%) 11 (18.0)
Atrial fibrillation, n (%) 8 (13.1)
Body weight (kg) 52.3 ± 10.8
Systolic blood pressure (mmHg) 145 ± 26
Diastolic blood pressure (mmHg) 74 ± 15
Heart rate (beat/min) 75 ± 13
Albumin (g/dL) 3.1 ± 0.6
Urea nitrogen (mg/dL) 50.0 ± 17.9
Creatinine (mg/dL) 7.3 ± 2.6
Sodium (mEq/L) 137 ± 4
C-reactive protein (mg/dL) 1.06 ± 2.19
Hemoglobin (g/dL) 10.4 ± 1.3
NT-proBNP (pg/mL) 13,851 (4764–34,279)
LVDd (mm) 45.7 ± 7.0
LVDs (mm) 30.8 ± 7.8
LVEF (%) 60.1 ± 13.4
Maximum WT (mm) 11.5 ± 1.7
UFR (kg/h) 0.51 ± 0.24
UFR/BW (1/h) 0.99 ± 0.42
ΔB-lines/pre B-lines 0.59 ± 0.22
Mean ± SD median (interquartile range), HD hemodialysis, ESKD end-stage
kidney disease, LVDd left ventricular end-diastolic dimension, LVDs left
ventricular end-systolic dimension, LVEF left ventricular ejection fraction, WT
wall thickness, UFR ultrafiltration rate, BW body weight
Table 2 Changes in echographic indices
Parameter At the start At the middle At the end
B-lines 11.8 ± 5.5 9.3 ± 5.3 5.2 ± 4.5
E (cm/s) 78.0 ± 25.8 57.5 ± 20.8 51.4 ± 20.3
A (cm/s)* 84.1 ± 29.7 78.3 ± 21.6 71.7 ± 19.8
IVC-ex (mm) 15.3 ± 3.8 12.0 ± 3.5 10.6 ± 3.4
IVC-in (mm) 10.5 ± 4.7 5.0 ± 3.1 3.0 ± 3.0
IVC collapsibility (%) 33.3 ± 21.0 61.3 ± 19.5 75.9 ± 19.7
Mean ± SD, E peak early diastolic filling velocity, A peak atrial filling velocity,
IVC inferior vena cava dimensions, ex exhalation, in inspiration
*Exclude 5 atrial fibrillations
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Discussion
We found that the number of B-lines at the start,
middle, and end of hemodialysis therapy was a risk
factor for mortality. Among them, the number of B-
lines at the end of hemodialysis therapy was the most
significant factor. Furthermore, we divided the pa-
tients according to the number of B-lines at the end
of hemodialysis therapy and found the mortality was
statistically higher in the 5 or more group than the
less than 5 group.
Lung ultrasound is a novel, well-validated technique
that allows reliable clinical estimates of lung water [5]. B-
lines can be evaluated anywhere (including extreme envir-
onmental conditions using pocket-sized instruments to
detect high-altitude pulmonary edema), anytime (during
dialysis), by anyone (even a novice sonographer after 1 h
of training), and on anybody (since the chest acoustic win-
dow usually remains patent even when an echocardiog-
raphy is not feasible) [10].
In this study, the IVC dimensions and peak E-velocity
were not associated with mortality. Both the IVC dimen-
sions and the peak E-velocity are related to the intravas-
cular volume; the IVC dimensions represent the right
ventricular preload [15], whereas the peak E-velocity
represents the left ventricular preload [16, 17]. On the
other hand, B-lines represent extravascular lung water.
We previously reported that the IVC dimensions and
the peak E-velocity were reduced mainly during the first
half of the dialysis period, while the number of B-lines,
which represents lung congestion, decreased significantly
mainly during the last half of the dialysis period [18].
This finding may be largely dependent on the time lag in
plasma refilling. Thus, even if the IVC dimensions are
sufficiently reduced, lung congestion may still exist and
should be treated.
There may be several possible pathophysiologies about
the relationship between the number of B-lines and
mortality. Lung congestion is a direct consequence of ei-
ther overall overhydration and/or cardiac dysfunction
which may affect poor outcome. At the same time, there
is a direct pathophysiological link between overall hydra-
tion and left ventricular function. As we previously re-
ported, the number of B-lines negatively related to body
weight and serum level of albumin and creatinine [8].
Two mechanisms have been proposed to explain the re-
lationship between hypoalbuminemia and congestion.
On the one hand, an increase in vascular permeability
Table 3 Cox proportional hazards analysis of the covariates for
all cause of death (simple analysis)
Hazard ratio
(95% CI)
P value
Age (per year) 1.08 (1.03–1.14) < 0.001
HD duration (per year) 1.00 (0.94–1.05) 0.9452
Albumin (per g/dL) 0.14 (0.06–0.33) < 0.0001
Urea nitrogen (per mg/dL) 0.98 (0.96–1.01) 0.134
Creatinine (per mg/dL) 0.72 (0.59–0.86) < 0.001
Sodium (per mEq/L) 0.98 (0.88–1.10) 0.727
C-reactive protein (per mg/dL) 1.06 (0.82–1.25) 0.583
Hemoglobin (per g/dL) 0.83 (0.57–1.18) 0.302
Ln[NT-proBNP] 1.72 (1.10–2.94) 0.014
Body weight (per kg) 0.95 (0.91–0.99) 0.019
Systolic blood pressure (per mmHg) 1.00 (0.98–1.01) 0.771
Diastolic blood pressure (per mmHg) 0.98 (0.96–1.01) 0.276
Heart rate (per beat/min) 1.00 (0.97–1.04) 0.815
LVDd (per mm) 0.96 (0.90–1.02) 0.215
LVDs (per mm) 1.01 (0.94–1.07) 0.794
LVEF (per %) 0.97 (0.94–1.01) 0.151
Maximum WT (per mm) 0.86 (0.67–1.09) 0.208
UFR (per kg/h) 0.07 (0.01–0.43) 0.004
UFR/BW (per 1/h) 0.35 (0.14–0.96) 0.042
ΔB-lines/pre B-lines 0.13 (0.03–0.78) 0.027
LVDd left ventricular end-diastolic dimension, LVDs left ventricular end-systolic
dimension, LVEF Left ventricular ejection fraction, WT wall thickness, UFR
ultrafiltration rate, BW body weight
Table 4 Cox proportional hazards analysis focusing on the echocardiographic changes during hemodialysis therapy for all cause of
death (simple analysis)
At the start At the middle At the end
Hazard ratio P value Hazard ratio P value Hazard ratio P value
(95% CI) (95% CI) (95% CI)
E (per cm/s) 0.99 (0.98–1.01) 0.491 0.99 (0.97–1.02) 0.648 0.99 (0.97–1.02) 0.594
A (per cm/s)* 1.00 (0.98–1.01) 0.73 1.01 (0.99–1.02) 0.374 1.01 (0.99–1.02) 0.339
IVC-ex (per mm) 1.02 (0.92–1.13) 0.688 1.02 (0.91–1.14) 0.718 0.99 (0.87–1.11) 0.834
IVC-in (per mm) 1.02 (0.93–1.11) 0.727 1.06 (0.93–1.21) 0.39 0.96 (0.82–1.11) 0.63
IVC collapsibility (per %) 0.99 (0.97–1.01) 0.575 0.99 (0.96–1.01) 0.186 1.01 (0.99–1.03) 0.573
B-lines (per number) 1.20 (1.09–1.32) 0.0002 1.17 (1.07–1.28) 0.0008 1.23 (1.12–1.37) 0.0001
E peak early diastolic filling velocity, A peak atrial filling velocity, IVC inferior vena cava dimensions, ex exhalation, in inspiration
*Exclude 5 atrial fibrillations
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mediated by an increase in hydrostatic venous pressure
may increase the transcapillary escape rate of albumin
from the intravascular to the extravascular space [19];
on the other hand, it is possible that intestinal conges-
tion favors albumin enteric losses [20]. The decrease in
oncotic pressure due to low serum level of albumin causes
the movement of water from intravascular to lung intersti-
tial. The malnutrition-inflammation-atherosclerosis syn-
drome affects mortality and hydration mechanics [18],
which may be another cause of the relation between num-
ber of B-lines and mortality.
The relationship between the number of B-lines and
mortality has been reported by investigators in several
countries. From Italy, the number of B-lines before
hemodialysis was reported to be a strong, independent
predictor of death and cardiac events [21]. From
Romania, the pre-hemodialysis number of B-lines was
shown to have a significant independent discriminating
power for survival [6]. The latter authors also reported
that the post-dialysis number of B-lines also had a sig-
nificant impact on survival when examined using a
crude Cox analysis, but the statistical significance was
lost after adjusting for other factors [6]. In our study, the
number of B-lines at the end of the hemodialysis therapy
was more strongly associated with mortality than the
number of B-lines at the start of the hemodialysis ther-
apy. The mortality was statistically higher in the 5 or
more group than in the less than 5 group at the end of
hemodialysis therapy. This difference may be caused, in
part, by the difference in the backgrounds of the
hemodialysis patients. Nishihira et al. measured the B-
line score of Japanese hemodialysis patients using a
method similar to that used in the Italian study. The B-
line score has been reported to be lower at both pre-
hemodialysis (8.9 vs. 33.5) and post-hemodialysis (4.7 vs.
16.1) in Japan compared with that in Italy [22]. Gargani
investigated patients who were admitted because of
acute heart failure and found that the number of B-lines
at the time of hospital discharge, but not at admission,
strongly predicted rehospitalization [23]. Another inves-
tigator also reported that residual pulmonary congestion
at discharge, as assessed using a B-line count ≥ 30, was a
strong predictor of all-cause death or heart failure
hospitalization [24]. Treatment-resistant pulmonary con-
gestion appears to be a poor prognostic factor among
patients with heart failure. We found low level of UFR/
body weight which also resulted in a poor outcome.
UFR/body weight represents the plasma refilling rate.
Condition of low level of plasma refilling rate, which re-
sults in refractory lung congestion, might affect mortal-
ity. Indeed, we revealed low level of ΔB-lines/B-lines at
the start resulted in a poor outcome.
Pulmonary congestion, which can remain after
hemodialysis therapy, may also be correlated with a poor
outcome. In a recent American study, a multivariate
Cox regression analysis showed that the number of B-
lines at the end of hemodialysis therapy was an inde-
pendent predictor of mortality [11]. Thorough removal
of the water and the prevention of lung congestion at
the end of hemodialysis seem to be important for a
Fig. 1 The comparison of survival curves between the group with 5 or more B-lines (n = 30) and the group with less than 5 B-lines (n = 31) at the
end of hemodialysis therapy. One-year survival was 55.4% in the 5 or more group whereas it was 89.8% in the less than 5 group. The mortality
was statistically high in the more than 5 group than the less than 5 group (P = 0.013)
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better prognosis. We reported that the patient heart rate
and the serum log (NT-proBNP) level were positively
correlated and the body weight and the serum albumin
and creatinine level were negatively correlated with the
number of B-lines [8]. Improving conditions that can
easily cause pulmonary congestion might also be useful
for improving patient outcome.
Our study had some limitations. The sample size was
relatively small, and the study was performed at a single
institution. B-line echo findings contribute to the dry
weight setting [2, 8, 9], but in our study, nephrologists
determined each dry weight using conventional markers
such as change of blood pressure, X-ray finding, or
serum level of biomarkers. We could not find a statisti-
cally significant relationship between number of B-lines
at any point and deaths from heart failure. That may be
because of the small number of studied participants. We
enrolled not only out patients but also hospitalized pa-
tients in this study, so the mortality was high and serum
level of albumin was low. Therefore, caution must be
exercised when generalizing our current results to differ-
ent hemodialysis patients. Measurement of B-line in
lung echogram is an operation-dependent examination.
But Bedetti et al. compared lung ultrasound information
obtained by experienced echocardiologists and by an in-
experienced echocardiographer with very limited (30′)
dedicated training on B-line assessment and reveal there
was a significant, tight correlation (r = 0.958, p < 0.001)
between the two observations in the same patient [25].
We generally use chest X-ray for evaluation of pulmon-
ary congestions. But we could not estimate chest X-ray
at the same time as echo examinations. Several groups
have shown how B-lines correlate reasonably well with
the imperfect gold standards of chest X-ray [26, 27] and
radiological score. The correlation is stronger when
intra-patient variations are considered [26]. Another
limitation of this study was that the investigator that
performed ultrasound was not blind for clinical informa-
tion of the patients such as age, gender, or clinical diag-
nosis. In addition, the limitations of lung ultrasound are
essentially patient-dependent. Obese patients may be
more difficult to examine because of the thickness of
their ribcages and soft tissues.
Conclusions
The number of B-lines at the start, middle, and end of
hemodialysis therapy may be correlated with mortality
among hemodialysis patients.
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